---
title: "Gilead Sciences, Inc. (GILD.US) Q1 2022 Earnings Conference Call"
description: "Gilead Sciences, Inc. (Gilead Sciences, Inc.) is a biopharmaceutical company engaged in the research, development, and commercialization of drugs in the field o"
locale: "en"
url: "https://longbridge.com/en/lives/10694"
parent: "https://longbridge.com/en/lives.md"
category: "Earnings Call"
---

# Gilead Sciences, Inc. (GILD.US) Q1 2022 Earnings Conference Call

**Status**: Unknown
**Category**: Earnings Call

## Description

Gilead Sciences, Inc. (Gilead Sciences, Inc.) is a biopharmaceutical company engaged in the research, development, and commercialization of drugs in the field of unmet medical needs. The company's main business areas include human immunodeficiency virus, acquired immunodeficiency syndrome, liver disease, hematology, oncology, inflammation, and respiratory system diseases. The company's Q1 2022 fiscal year report is expected to be released on April 28, 2022 (Eastern Time).

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.